GlassScriptPhysician profile
Tara Rainey
NPI 1235752536
$2,353.19
in general payments reported to CMS, 2019-2025
16 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.35 · 2022: $278 · 2023: $807 · 2024: $1,154 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,951 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,951.39 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $874.80 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $227.07 | 2022-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Teva Pharmaceuticals USA, INC. | $210.81 | 2023-2025 | Austedo Xr, Uzedy |
| Neurocrine Biosciences, INC. | $209.71 | 2022-2024 | Ingrezza |
| Lundbeck LLC | $172.29 | 2022-2025 | Rexulti |
| Axsome Therapeutics, INC. | $163.57 | 2022-2024 | Auvelity |
| Janssen Pharmaceuticals, INC | $142.99 | 2022-2024 | Spravato, Invega Sustenna |
| Alkermes, INC. | $73.77 | 2022-2024 | Lybalvi |
| Idorsia Pharmaceuticals US INC | $56.12 | 2023 | Quviviq |
| Tris Pharma INC | $52.32 | 2023-2024 | Dyanavel Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $44.72 | 2022-2023 | |
| Biogen, INC. | $42.28 | 2024-2025 | Zurzuvae |
| Corium, LLC | $29.29 | 2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $20.57 | 2024 | Trintellix |
| E.R. Squibb & Sons, L.L.C. | $16.62 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $16.26 | 2023 | Loreev Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Rainey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.